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VIPR: A probabilistic algorithm for analysis of
microbial detection microarrays
Adam F Allred1, Guang Wu1, Tuya Wulan1, Kael F Fischer2, Michael R Holbrook3,4, Robert B Tesh3, David Wang1*

Abstract
Background: All infectious disease oriented clinical diagnostic assays in use today focus on detecting the presence
of a single, well defined target agent or a set of agents. In recent years, microarray-based diagnostics have been
developed that greatly facilitate the highly parallel detection of multiple microbes that may be present in a given
clinical specimen. While several algorithms have been described for interpretation of diagnostic microarrays, none
of the existing approaches is capable of incorporating training data generated from positive control samples to
improve performance.
Results: To specifically address this issue we have developed a novel interpretive algorithm, VIPR (Viral
Identification using a PRobabilistic algorithm), which uses Bayesian inference to capitalize on empirical training
data to optimize detection sensitivity. To illustrate this approach, we have focused on the detection of viruses that
cause hemorrhagic fever (HF) using a custom HF-virus microarray. VIPR was used to analyze 110 empirical
microarray hybridizations generated from 33 distinct virus species. An accuracy of 94% was achieved as measured
by leave-one-out cross validation. Conclusions
VIPR outperformed previously described algorithms for this dataset. The VIPR algorithm has potential to be broadly
applicable to clinical diagnostic settings, wherein positive controls are typically readily available for generation of
training data.

Background
The field of viral diagnostics, which has traditionally followed a “one virus-one assay” paradigm, has been revolutionized by the introduction of diagnostic microarrays
[1-10]. It is now possible to test for the presence of
thousands of viruses simultaneously in a single assay. A
microarray-based approach is particularly effective for
viral diagnosis of diseases that have a common phenotype, but may be caused by any of a number of different
viruses. For example, acute respiratory disease, encephalitis and hemorrhagic fever are all disease syndromes
known to be caused by a spectrum of viral pathogens.
Microarrays specifically focused on the diagnosis of
respiratory disease [11-14] and encephalitis [3-5] have
been described, as have much broader pan-viral microarrays [1,2,8]. A wide range of probe design strategies
and microarray platforms can be used for diagnostic
microarrays. Independent of the probe design strategy
* Correspondence: davewang@borcim.wustl.edu
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or platform, a key component that is absolutely essential
for all diagnostic microarrays is an objective method for
interpreting the raw hybridization patterns. While many
diagnostic microarrays have been described, there are
only three published algorithms, E-Predict [15], DetectiV
[16] and PhyloDetect [17], with downloadable or webaccessible software that are available for analyzing data
from diagnostic microarrays.
The typical goal of diagnostic virology assays is to
determine the presence or absence of one or more
viruses from a finite, defined list of candidate viruses
known to cause the disease in question. In clinical laboratories, samples of each candidate virus to be detected are
typically readily available and can be used as positive controls. Our goal was to develop an interpretive algorithm
for diagnostic microarrays that could take advantage of
the existence of such positive controls to generate a
training data set to guide subsequent analyses.
Toward this end, we developed a probabilistic algorithm for the purpose of analyzing diagnostic microarrays. This class of algorithms has been applied to
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numerous problems in biology. For example, hidden
Markov models (HMMs) and the more youthful conditional random fields (CRFs) have allowed researchers to
make important inferences about sequence structure
and function [18,19]. Bayesian inference in a probabilistic framework offers a distinct advantage of capitalizing
on empirical data to guide future predictions as compared with methods that are based solely on computational prediction of genome-to-probe binding. In
addition, the power of utilizing probabilities as opposed
to discretizing a host of parameters when considering
possible solutions means that global calculations are less
likely to be influenced by poor choices made locally. To
date, no Bayesian algorithm for diagnostic microarrays
has been described.
In this paper, we describe a novel probabilistic algorithm that relies on Bayesian inference for analysis of
diagnostic microarrays. To validate this approach, we
focused on analysis of the set of viruses known to cause
hemorrhagic fever. HF symptoms include severe vascular damage, hemorrhage, high fever, and shock and can
frequently lead to death [20,21]. HF viruses belong to
four virus families: Arenaviridae, Bunyaviridae, Flaviviridae and Filoviridae. A custom microarray was designed
to detect all known HF viruses and many of their close
relatives. Specimens representing virtually every virus
species known to cause HF were procured and hybridized to microarrays for the purpose of validating our
algorithm. Furthermore, we compared VIPR’s performance to that of the existing interpretive algorithms
that are not capable of utilizing training data in this
fashion.

Methods
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using standard Trizol® protocols and was randomly
amplified as previously described [2]. The resulting
amplified material was then coupled to a fluorescent
dye and hybridized to the HF microarray. Raw data
measurements were collected using GenePix Pro® software. In total, 110 hybridizations were performed (102
positive controls + 4 Vero negative controls + 4 C6/36
negative controls). All raw microarray data are available in NCBI GEO (accession GSM534862 through
GSM534971). These 110 hybridizations constituted a
set of positive and negative controls used for validation, a subset of which was used in training our
algorithm.
VIPR normalization and transformation (Figure 1A)

For each sample in the training set, a unit-vector normalization was applied as shown, where x i represents
the i th intensity for a given hybridization. Then, each
normalized intensity was loge transformed. As given in
Equation (1), xiNT is the normalized, transformed value
for that intensity. Normalization was performed to
account for variation in reagent concentrations or fluorescence across the microarray. Log transformation of
the data was desirable for the estimation of normal distributions.

x iNT

⎛
⎜
= log ⎜
⎜
⎝

⎞
⎟
⎟
∑ x i2 ⎟
⎠
xi

(1)

Note that in the following calculations, all intensities
have been normalized and transformed although the
superscript NT does not appear.

Microarray design

14,864 oligonucleotide probes were designed using a
taxonomy-based approach as described previously [22]
except that the Agilent® 8 × 15 K platform was used and
probes were 35, 45 or 60 nucleotides in length. The
probes were designed to bind to viral genomes from the
four families that contain all viruses known to cause HF:
Arenaviridae, Bunyaviridae, Filoviridae, and Flaviviridae. Probes of different lengths were designed to
account for different levels of conservation between viral
taxa. For example, longer probes were included to represent regions of strong conservation, while shorter probes
were included to distinguish closely related virus species
in order to increase specificity.
Hybridization of HF viruses to microarray

A total of 51 strains of 33 distinct virus species (see
Table 1) obtained from the World Reference Center
for Emerging Viruses and Arboviruses were grown in
either Vero cells or C6/36 cells. RNA was extracted

VIPR prediction of On and Off states (Figure 1B)

Candidate genomes to be scored in the VIPR algorithm
were limited to all complete genomes in the NCBI virus
RefSeq database as of 6/20/2008. The entire set of oligonucleotide probes on the microarray was aligned using
BLASTN against each of the RefSeq viral genomes. Theoretical free energies of hybridization were then calculated from the aligned sequences using code included
with OligoArraySelector [23]. If the free energy associated with binding of a given viral genome/oligonucleotide pair was computed to be less than -30 kcal/mol, the
probe was assigned the On state for that genome; otherwise, the probe was assigned the Off state. The choice of
-30 kcal/mol was based on the observation that this
threshold represents the weakest binding reported for
long-oligo broad specificity microarrays [23]. A given
viral genome was included in the list of potentially
detectable candidate viral genomes if at least three oligonucleotide probes were expected to bind to that
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Table 1 Viruses hybridized to the diagnostic microarray
Virus

Family

Causes HF

# of strains hybridized

Amapari virus

Arenaviridae

No

1

Guanarito virus

Arenaviridae

Yes

4

Ippy virus

Arenaviridae

No

1

Junin virus

Arenaviridae

Yes

1

Lassa virus

Arenaviridae

Yes

2

Lymphocytic choriomeningitis virus

Arenaviridae

No

1

Machupo virus

Arenaviridae

Yes

1

Mobala virus

Arenaviridae

No

1

Mopeia virus

Arenaviridae

No

1

Sabia virus

Arenaviridae

Yes

1

Tacaribe virus

Arenaviridae

No

1

California encephalitis virus

Bunyaviridae

No

1

Crimean-Congo hemorrhagic fever virus

Bunyaviridae

Yes

4

Hantaan virus

Bunyaviridae

Yes

1

La Crosse virus

Bunyaviridae

No

1

Ngari virus

Bunyaviridae

Yes

1

Puumala virus

Bunyaviridae

Yes

1

Rift Valley fever virus

Bunyaviridae

Yes

3

Seoul virus

Bunyaviridae

Yes

1

Toscana virus

Bunyaviridae

No

1

Angola marburgvirus

Filoviridae

Yes

1

Reston ebolavirus

Filoviridae

No

1

Sudan ebolavirus

Filoviridae

Yes

1

Zaire ebolavirus

Filoviridae

Yes

1

Gabon ebolavirus

Filoviridae

Yes

1

Dengue virus 1

Flaviviridae

Yes

2

Dengue virus 2

Flaviviridae

Yes

2

Dengue virus 3

Flaviviridae

Yes

2

Dengue virus 4

Flaviviridae

Yes

2

Kyasanur Forest disease virus

Flaviviridae

Yes

2

Omsk hemorrhagic fever virus

Flaviviridae

Yes

4

Rocio virus

Flaviviridae

No

1

Yellow fever virus

Flaviviridae

Yes

2

genome (i.e. were expected to be On). A total of 101
candidate genomes met these criteria.
VIPR calculation of posteriors (Figure 1A)

Posterior probabilities were calculated for each probe i
according to Bayes’ rule, (2) and (3). Yi and xi represent a
random variable and an observed intensity, respectively.
P(On | Yi = x i ) =

P(Yi = x i|On)P(On)marg
∑ On,Off P(Yi = x i|state)P( state)marg

P(Off | Yi = x i ) = 1 − P(On | Yi = x i )

(2)
(3)

Likelihoods for each probe were determined using
normal distributions derived from two sets of normalized loge transformed intensities: those corresponding to
the On states for a given probe (4), and those corresponding to the Off states (5).
P(Yi | On) ~ N( i ,on, i2,on )

(4)

P(Yi | Off ) ~ N( i ,off , i2,off )

(5)

The probe-specific On and Off distributions are
derived from the training set where the probe On/Off

Unknown
x = [ x1 x2 . . .

x3

P(Off |Yi =x i )

P(On |Yi =x i )

Posteriors

0

1

x1

x2

x3

4. Multiply posteriors to
obtain likelihoods

3. Compute posterior probabilities via Bayes’ Rule

x2

]
m

x

1. Normalize/transform array data
2. Estimate On and Off Distributions for
each probe from training data

x1

y =

y11 y12 . . y1n
y21
.
.
.
.
.
ym1 . . . ymn

Training Set

Empirical Array Input

On

virus t

Off

On

Probe 2

On

Off

Probe 3

3’

3’

Probe 3

Probe 2

Probe 1

0
L(x|virust ) = P(On |Y1 =x1 )

1

0
L(x|viruss ) = P(On |Y1 =x1 )

1

x P(Off |Y2 =x2 )

x P(On |Y2 =x2 )

x P(On |Y3 =x3 )

x P(Off |Y3 =x3 )

Calculate
significance and
sort by p-value
to obtain best
prediction

2. Choose either the On or Off posterior for each probe depending
on its predicted binding to the genome under consideration

On

Probe 1

1. Predict whether each probe binds (On) or
does not bind (Off) to each VHF genome

Sequence Input from Genbank

virus s

5’

5’

Likelihoods

virus t

virus s

Genomes

C

B

Figure 1 Flow of VIPR. The VIPR probabilistic model incorporates both empirical array data as well as sequence data from GenBank to calculate likelihoods for each candidate virus. A) Posterior
probabilities are calculated for each probe. B) The On or Off posterior is chosen for each probe based on predicted binding to candidate genomes. C) Posteriors are multiplied to obtain a
likelihood for each candidate virus.
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states are defined by the identity of the virus in each
hybridization.
VIPR priors

Priors were calculated (6,7) in a probe-specific manner
and were designed to incorporate two calculations
derived from the composition of the microarray as well
as the composition of the set of candidate viruses under
evaluation: (a) the percentage of probes predicted to be
On for the candidate virus under consideration, represented as P(On)pred; (b) the number of candidate viruses
that share that probe’s On/Off prediction (i.e. if four
candidate viruses, including viruss, are predicted to be
On for a given probe, then P(viruss|On) = 1/4 for that
probe). Marginalizing over the possibility of an On or an
Off prediction calls for a second invocation of Bayes’
rule:
P(On) marg =

P(virus s |On)P(On) pred
Σ On,Off P(virus s |state)P( state) pred

P(Off ) marg = 1 − P(On) marg

(6)

(7)

VIPR calculation of hybridization likelihoods (Figure 1C)

Because of the possibility of underflow, all likelihood
calculations were made in log space, though they are
expressed here in probability space. The likelihood (8)
of the observed hybridization vector, x, was calculated
for each of n viral genomes. The posteriors included in
the product were chosen so as to reflect the expected
state of a particular probe for viruss. On states for viruss
are indexed from i = 1 to a while Off states are indexed
from j = 1 to b as shown in formulas (9) and (10),
respectively.
L( x | virus s ) = L1 × L 2

(8)

a

L1 =

∏ P(On | Y = x )
i

i

(9)

i =1
b

L2 =

∏ P(Off | Y

j

= x j)

(10)

j =1

From the 100 null scores for each candidate virus, a
mean and standard deviation were calculated. The
resulting p-value reflects the percentage of the null distribution that is greater than or equal to the actual
score. When assessing the significance of a given candidate, a Bonferroni correction was applied so that 0.05, a
generally accepted level of significance, was divided by
the total number of candidate viruses (101) i.e. a candidate was considered significant if its p-value was less
than 5 × 10-4.
Assessing the accuracy of VIPR

From the total 110 empirical hybridizations, 108 were
chosen as suitable for training on the basis of percentage of well-behaved probes among those predicted to
be On. Two hybridizations of Ippy virus to the array
were excluded from training because the percentage of
probes designed to bind to Ippy virus that evinced a
sufficient separation (p < 0.001 by student’s t-test)
between the On and Off distributions was less than ten
percent. For the initial cross-validation, the subset of
108 arrays was divided into a training set consisting of
107 arrays and a validation set consisting of a single
array. This was done 108 times, leaving out a different
array each time. The two arrays that did not meet the
criterion for inclusion in the training set were tested
using all 108 selected arrays for training. For each array,
the best prediction was determined by sorting significant candidate viruses (p < 5 × 10 -4 ) by p-value and
then by likelihood. In the case where no virus was significant, the array was considered negative. Algorithm
accuracy was computed using the formula, Accuracy =
(TP + TN)/(TP + TN + FP + FN), where TP is the
number of true positives, TN is the number of true
negatives, FP is the number of false positives, and FN is
the total number of false negatives. In the case where
the fully sequenced genome of a viral subspecies was
not available, an accurate prediction on the species level
constituted a true positive. There was also one case
where the genome of a subspecies (La Crosse virus) was
used as a substitute for a hybridized species (California
encephalitis virus) because the complete sequence of
California encephalitis virus was not available. These
designations of species and subspecies are according to
NCBI taxonomy.
Exploring alternative priors

Calculating significance of VIPR results

To determine the significance of the results obtained, we
computed a p-value for each candidate virus by permuting the set of priors for the candidate over the set of
likelihoods P(Off |Yi = xi ) so as to estimate a null distribution of scores (n = 100 permutations) against which
the actual score for that candidate could be compared.

In a separate analysis, VIPR’s accuracy was assessed
over a space of arbitrary priors rather than deliberately
specifying priors using Equations (6) and (7). Thus, the
marginalized priors P(On)marg and P(Off)marg in Equation (2) were replaced with priors that ranged iteratively from 0.1 to 0.9. For each iteration, one prior pair
i.e. P(On), P(Off) where P(Off) = 1- P(On) was chosen
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for all On probes, while a separate pair was chosen for
all Off probes. Thus, while the prior pair between the
On and the Off probes could differ, the prior pair
between any two On probes or between any two Off
probes was the same. Hence, the space explored represents successive iterations of independently varying the
On prior pair and the Off prior pair with variations
made at a step size of 0.1. As before, p-values were
calculated to assess the significance of VIPR results,
except that 20 permutations were run for each candidate virus instead of 100.
Exclusion of replicate hybridizations

Four independent strains of each of the following
viruses, Crimean-Congo hemorrhagic fever, Guanarito
virus and Omsk hemorrhagic fever virus were cultured
in Vero cells. These viruses represent three of the four
HF virus families. As with the other viruses in the positive control dataset, these viruses were hybridized in
duplicate (3 viruses × 4 strains per virus × 2 hybridizations for each strain = 24 hybridizations). These 24
hybridizations were used to assess the effect that leaving
out both replicates of a strain would have on cross-validation. VIPR predictions were made as described for the
leave-one-out cross validation except that replicate
hybridizations were excluded from training for the subset of 24 arrays. The number of accurate predictions
made by VIPR out of the total 24 hybridizations was
calculated.
Comparison to existing diagnosis algorithms

Three algorithms, E-Predict, DetectiV and PhyloDetect,
were available for comparison to VIPR. E-Predict [15]
was used to calculate Uncentered Pearson correlations.
A custom E-matrix for the HF dataset was prepared as
described by Urisman et al. A given viral genome was
included in the list of potentially detectable candidate
viral genomes if at least three oligonucleotide probes
were expected to bind to that genome. Default normalizations (’Sum’ for the intensity vector and ‘Quadratic’
for the E-matrix) were applied. 110 correlations were
used to estimate each null distribution of correlations
from the set of HF arrays. These distributions were fit
using the Shapiro-Wilk normality test as described [15].
The same significance threshold that was applied to
VIPR predictions (p < 5 × 10-4) was also applied to EPredict. Background-corrected intensities were loaded
into DetectiV [16] and normalized in two independent
ways: first using the median option, and second, against
a Vero or C6/36 array serving as a negative control. The
filtered results (mean log ratio > 1) for each array were
then sorted by p-value to determine the top-scoring
virus. The same significance threshold that was applied
to VIPR predictions (p < 5 × 10-4) was also applied to
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DetectiV. Hybridization intensities were inputted to
PhyloDetect [17] as binary vectors where a probe was
considered ‘present’ if its intensity was greater than the
median background signal plus twice the background
standard deviation. The E-matrix constructed for E-Predict was converted to binary values (xi ≥ -60 kcal/mol
®1; otherwise ® 0). The fnr parameter was set to 0.10.
Results were sorted first by likelihood and then by number of present probes to determine the top candidate. A
likelihood above the threshold 0.05 constituted a positive prediction. The same formula to calculate accuracy
for VIPR was used to calculate accuracies for E-Predict,
DetectiV and PhyloDetect.

Results
RNA was purified from cell cultures that were infected
with each of the viruses shown in Table 1. These viruses
were selected to include almost all of the viruses known
to cause HF; only a few very recently identified HF
viruses, such as Chapare virus [24] and Lujo virus [25],
were not included. To assess whether these viruses
could be distinguished from close relatives that are not
associated with HF, additional viruses were also selected
from the same families for testing. For each of the 51
virus cultures, following random amplification and fluorescent labeling, two microarrays were hybridized generating a total of 102 empirical hybridizations using virally
infected samples. In addition, eight negative control
hybridizations (four from uninfected Vero cells and four
from uninfected C6/36 cells) were performed.
We developed VIPR as an objective approach for analyzing diagnostic microarray data (VIPR is available for
download from http://ibridgenetwork.org/wustl/vipr).
VIPR incorporates both sequence data from GenBank as
well as empirical array data to classify microarray hybridizations of samples with unknown viral infections
(Figure 1). From these data, normal distributions corresponding to On and Off states for each probe were
estimated.
Empirical distributions and their normal approximations for two representative probes are shown in Figure
2. Figure 2A depicts a highly informative probe since
there is effectively no overlap between the On and Off
distributions for that probe. In contrast, the distributions in Figure 2B overlap substantially. Gradations
between these two extremes constitute probes of intermediate informative value. Posterior probabilities were
calculated via Bayes’ rule for each probe given the
observed intensity from an unclassified array. These posterior probabilities were multiplied to obtain likelihoods
for each candidate virus [Additional file 1].
For identification of HF viruses, the algorithm was
trained using a subset of the total 110 hybridizations.
To select a suitable subset for training purposes, we
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Figure 2 Examples of On and Off distributions for two probes. A) One representative probe with highly resolved On and Off distributions
based on the training set data. B) One representative probe where the On and Off distributions overlap. Empirical distributions (blue = Off, red =
On) and estimated distributions (cyan = Off, pink = On) are shown.

identified 108 hybridizations for which at least 10% of
the probes predicted to be On had intensities that differed significantly (p < 0.001) from that probe’s Off distribution. To assess VIPR’s performance on the 108
selected arrays, we performed leave-one-out cross validation so that the selected arrays were divided into a
training set (n = 107) and a validation set (n = 1). The
remaining two arrays (not included in the training set)
were tested using the entire set of selected arrays (n =
108) for training.
An example of VIPR’s output for a representative
Dengue virus 3 hybridization is shown in Table 2. Likelihood scores for all candidate viruses for each microarray are available in the supporting material. We
measured the accuracy with which we could make predictions for the virally infected and negative control
arrays. VIPR made accurate predictions for 104 out the
total 110 arrays. There were five false negatives and one
false-positive, corresponding to an accuracy of 94%. The
misclassified arrays are shown in Table 3.
For all Bayesian methods, one question that must be
addressed is how to choose appropriate priors. From
many possible choices, we selected priors in this study
based upon the composition of the probes in the microarray as well as the makeup of the candidate genomes
Table 2 Five highest scoring candidates for a Dengue 3
hybridization.
Rank Virus

Family

log(L)

under evaluation. In order to define the dependency of
our algorithm’s accuracy on the choice of priors, VIPR’s
accuracy was assessed over a range of possible prior
pairs, independently varying the pair used for probes
expected to be On versus the pair used for those
expected to be Off. Hence, the space explored represents
different combinations of prior pairs whose values lie
between 0.1 and 0.9 with variations made at step size of
0.1, and with the sum of P(On) and P(Off) defined as 1.0
for each prior pair. 20 permutations were run for each
candidate virus to compute p-values. Results are shown
in Figure 3. Accuracy varied depending of the choice of
priors, but remained fairly stable (between 85% and
97%) over a wide range of prior pairs, suggesting that
the method is relatively insensitive to the choice of
priors.
For the 24 hybridizations representing four strains
from each of three species (Crimean-Congo hemorrhagic fever, Guanarito virus, Omsk hemorrhagic fever
virus), a second cross-validation was performed in
which both replicates corresponding to a particular
strain were excluded from training when making VIPR
Table 3 The six arrays that were misclassified by VIPR.
False positives
Chip#

Hybridized virus

Top scoring virus (p < 5e-4)

207

Dengue virus 3

Dengue virus 4

False negatives

p-value

Chip#

Hybridized virus

Top scoring virus (p < 5e-4)

1 Dengue virus 3

Flaviviridae

-352

0

462

Kyasanur Forest disease virus

none

2 Dengue virus 4

Flaviviridae

-391

0

463

Kyasanur Forest disease virus

none

3 Dengue virus 2

Flaviviridae

-539

0

464

Kyasanur Forest disease virus

none

4 Dengue virus 1

Flaviviridae

-599

0

221

Ippy virus

none

5 Psittacid herpesvirus 1

Bunyaviridae

-433

1.0

245

Ippy virus

none

Allred et al. BMC Bioinformatics 2010, 11:384
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Figure 3 Cross-validation results for different combinations of prior pairs.

predictions for those arrays. Leaving out both replicates
for these particular strains was possible because there
remained three other positive control strains of the
same species in the training set. This could not be done
in the case where only one strain of a species was present among the positive controls because it would render the training set devoid of any representatives of that
species. VIPR analysis of the subset of arrays that represent viruses where multiple strains are present in the
training set demonstrated robust prediction (24/24
arrays accurately predicted).
We compared the performance of VIPR to that of
existing algorithms for analyzing diagnostic microarrays.
E-Predict [15], the first algorithm expressly designed for
interpretation of viral microarrays, uses a theoretical
energy matrix to compute correlations between experimental hybridizations and genome-derived energy vectors [15]. As shown in Table 4, VIPR (94% accuracy)
outperformed E-Predict (61% accuracy) for the same set
Table 4 Accuracy of VIPR compared to other methods for
this dataset.
Algorithm
VIPR

Accuracy (%)
94

DetectiV

76-83

E-Predict

61

PhyloDetect

49

of positive and negative control arrays. One possible
explanation for E-Predict’s low performance for this set
of arrays is the lack of sufficient data to estimate accurate null distributions of scores by the Shapiro-Wilk criterion to be used to calculate p-values. For this dataset
only 110 arrays were available for the estimation of null
distributions for E-Predict, whereas over one thousand
arrays were used by Urisman et al. [15] to calculate
these distributions. This is supported by the fact that
the virus with the highest raw score as determined by
E-Predict is the true virus for 84 of the 102 positive
control arrays.
DetectiV [16] is an R-based method for significance
testing for microbial detection microarrays. Significance
testing involves data normalization against one of the
following: an array’s median value for all probes, the
mean value of a set of designated control probes, or a
control array. No designated control probes, in the
sense described by the DetectiV algorithm, were
included in our design; therefore, the median and control array normalization options were used to analyze
our data. After performing significance testing, the
results were filtered to exclude groups whose mean log
ratio was less than or equal to one. Sorting the filtered
results by p-value then revealed a best prediction for
each array. An accuracy of 69% was achieved using the
median normalization method. Higher accuracies were
achieved using the negative arrays with the control array
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normalization option. These accuracies ranged from 76%
to 83% depending on which of the eight uninfected samples in our dataset was used as the control array.
PhyloDetect has previously been applied to viral diagnostic microarrays by increasing its ‘false negative rate’
parameter [17]. PhyloDetect, unlike VIPR, E-Predict and
DetectiV, requires its hybridization inputs to be binary.
To achieve this, we created a binary vector for each
array where a probe was given a value of ‘1’ if its intensity was greater than the median background signal plus
twice the background standard deviation, and ‘0’ otherwise. The theoretical microbial candidate profiles
required for PhyloDetect are also binary. While the
authors of PhyloDetect applied a stringent predicted
binding energy threshold (-80 kcal/mol or less) to make
binary present/absent predictions, our probe set, which
included probes ranging in length from 35 to 60 nucleotides, could not tolerate such a stringent cutoff without
resulting in some candidates having zero probes predicted as ‘present.’ Thus, we predicted a present probe
when the corresponding binding energy was calculated
to be -60 kcal/mol or less. After analysis of our data, we
computed an accuracy of 49% for PhyloDetect.

Discussion
The inherently parallel nature of DNA microarrays lends
itself well to diagnostic applications seeking to simultaneously test for many microbial agents. While many
diagnostic microarrays have been described [1-10] there
is a relative lack of methods to objectively interpret
these microarrays.
One key feature of a true diagnostic microarray is that
the targets to be detected are typically well defined. Thus,
specimens infected with these targets should be available
for use as positive controls. In this study, we developed a
novel interpretive algorithm for analysis of diagnostic
microarrays that takes advantage of the existence of positive controls that can serve as a training set. VIPR performed with high accuracy (94%) as measured by leaveone-out cross validation. Since VIPR outperformed EPredict, DetectiV and PhyloDetect for this dataset, this
underscores the utility of using a set of known viruses
together with a probabilistic algorithm to diagnose viral
disease. Though we have not applied our algorithm to
other diseases, we anticipate that this strategy would
similarly be preferable to a non-Bayesian approach for
diagnosis of other diseases of multiple etiologies whose
microbial spectrum is well defined and for which positive
and negative control specimens are available.
Only one false positive resulted from the cross-validation, which was a Dengue virus 3 sample being classified
as Dengue virus 4. Dengue virus 3 was the second best
prediction for this array, with both Dengue virus 4 and
Dengue virus 3 achieving a p-value of 0.0. The other five
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microarrays that were misclassified by VIPR, all of which
were called as virus negative, were derived from three
virus cultures. None of these samples was accurately classified by E-Predict, DetectiV, or PhyloDetect. Given that
these samples evaded accurate classification by all three
algorithms, one possibility for the lack or detection of
virus in these samples is the samples used as positive
controls may have been present in abundance below the
sensitivity limit of the microarrays. Another plausible
explanation is that all or most of the probes designed to
detect these viruses do not behave as predicted. In this
case, redesigning the probes for these viruses would be
the best way to improve the accuracy of the platform.
Comparing the On and Off distributions for probes
designed to bind to these viruses reveals that among
those viruses that were hybridized to the array, Ippy virus
and Kyasanur Forest disease virus exhibited the highest
percentage of On probes that displayed no significant difference (p < 0.001) in intensity between the On and Off
distributions (94% and 85% respectively). However, since
VIPR’s accuracy is inherently limited by the performance
of the probe set, and the response of the probe set is
determined by the identity and abundance of the target
microbes, we are unable to distinguish between the possibilities of low-titer virus and misbehaving probes.
Other potential caveats related to our method include
a limited ability to estimate the true intensity distribution of On states for a probe because of the small number of intensities in the training set that correspond to
an On state. Hence, one way to improve the accuracy of
estimation of these distributions would be to increase
the number of positive control arrays in the training set.
Depending on the degree of sequence divergence among
the known strains of a given virus, it may also be important to represent the known diversity of related strains
in the training set. However, we emphasize that even
with the limited number of microarray hybridizations
performed in this study, 94% accuracy was achieved.
The choice of prior probabilities could also be problematic in some circumstances. We found that prior estimation based on predicted binding of probes to viral
genomes resulted in robust virus prediction. Moreover,
accuracy remained fairly stable (between 85% and 97%)
over a wide range of prior combinations. Another
potential caveat with the VIPR algorithm is that the distribution of the loge of the intensities was assumed to
be normally distributed. Gross violations of this assumption could have pejorative effects on prediction.
One limitation of a leave-one-out cross-validation in
our case is that there is a possibility of overfitting due
to the presence of replicate hybridizations in the training set. However, an analysis of a subset of arrays that
represented several different strains of viruses (CrimeanCongo hemorrhagic fever virus, Guanarito virus and
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Omsk hemorrhagic fever virus) demonstrated that
removing both replicate hybridizations for a given strain
from the training set while retaining those from the
other strains resulted in accurate prediction in every
case. This subset of viruses represented three of the four
families of HF viruses. While this analysis does not completely rule out the possibility of overfitting, it clearly
demonstrates that VIPR can make accurate predictions
even when replicate arrays are removed from training,
as long as hybridizations representing strains from the
same species are present. Additionally, VIPR outperformed the other three algorithms for this subset. E-Predict, DetectiV and PhyloDetect accurately classified 14,
16, and 8 of the 24 arrays, respectively.
While the results of our study represent a proof of
principle using carefully controlled positive and negative controls for validation, it is anticipated that a
probabilistic algorithm will be useful in clinical laboratory settings to analyze microarrays like the one
described. Testing VIPR using clinical datasets will be
the focus of future studies. In the case of diseases for
which samples representing in vivo human infections
are available, such would be the desired dataset for
training. In the case of HF, however, clinical specimens
from human infections are not generally available;
therefore, it will be necessary to investigate the use of
different kinds of specimens as training data for the
probabilistic algorithm. These datasets could include
specimens from infected animals or viruses harvested
from culture and spiked into human sera.
As currently implemented, VIPR only looks for single
virus effects. Possible improvements to the software
might include the addition of functionality to detect the
presence of co-infections and reassortant viruses. This
could be accomplished by including among the list of
candidates for which likelihoods are computed theoretical combinations of sets of On posteriors from different
viruses. Equations (11) through (14) extend the singlevirus likelihood calculation implemented by VIPR to the
case where two viruses, s and t are present.
L( s | virus s,t ) = L1 × L 2 × L 3

(11)

Conclusions
We developed a probabilistic algorithm that relies on a
training set of empirical hybridizations that accounts for
probe-specific behaviors. Application of this algorithm
to a dataset of cultured viruses that cause HF resulted
in high accuracy virus identification. Though we report
the application of VIPR only in the context of diagnosis
of HF, our method of detection is theoretically applicable to any microbial detection problem in which a set
of positive and negative control hybridizations is available. Our implementation of a probabilistic algorithm
demonstrates the power of a Bayesian approach for discerning important hybridization signals from a complex
mixture of nucleic acids. This, in turn, should prove to
be of great value as microarray-based diagnostics play
more prominent roles in clinical and public health
laboratories.
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